Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome

Keyphrases

• Acute Effects 100%
• Glucagon-like 100%
• Short Bowel Syndrome 100%
• Teduglutide 100%
• Intestinal Adaptation 100%
• Intestine 66%
• Placebo 50%
• Pediatric Patients 33%
• Gastrojejunostomy 33%
• Gut Function 33%
• Immunohistochemistry 16%
• Adult Patients 16%
• Dose Effect 16%
• Resection 16%
• Small Intestine 16%
• Ki-67 16%
• Protein Production 16%
• Abdominal Wall 16%
• Malabsorption 16%
• Weight Increase 16%
• Total Parenteral nutrition 16%
• Synthetic Humans 16%
• Adaptation Period 16%
• Neonatal piglets 16%
• FABP2 16%
• Gut Resection 16%
• Digestive Enzyme Activity 16%
• Enteral nutrient 16%
• Functional Endpoints 16%
• Chga 16%
• Trophicity 16%
• GLP2R 16%
• Neonatal Short Bowel Syndrome 16%
• Villin 16%

Medicine and Dentistry

• Glucagon Like Peptide 2 100%
• Short Bowel Syndrome 100%
• Teduglutide 100%
• Intestine 66%
• Placebo 50%
• Gut 50%
• Surgery 33%
• Pediatrics Patient 33%
• Jejunostomy 33%
• Patient with Short Bowel Syndrome 33%
• Immunohistochemistry 16%
• Body Weight 16%
• Protein Synthesis 16%
• Abdominal Wall 16%
• Small Intestine 16%
• Malabsorption 16%
• Total Parenteral Nutrition 16%
• Villin 16%